AIA
DXCM icon

Avalon Investment & Advisory’s DexCom DXCM Stock Holding History

Avalon Investment & Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,188
Closed -$234K – 346
2021
Q2 		$234K Sell
2,188
-1,060
-33% -$102K 0.01% 340
2021
Q1 		$292K Sell
3,248
-132,304
-98% -$12.4M 0.01% 320
2020
Q4 		$12.5M Buy
135,552
+1,284
+1% +$115K 0.26% 116
2020
Q3 		$13.8M Sell
134,268
-5,796
-4% -$606K 0.31% 101
2020
Q2 		$14.2M Sell
140,064
-16,700
-11% -$1.49M 0.33% 97
2020
Q1 		$10.6M Buy
+156,764
New +$9.75M 0.27% 110

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avalon Investment & Advisory's DXCM Position: Q3 2021 in Review

Avalon Investment & Advisory sold out of DexCom (DXCM) in Q3 2021, closing a stake of 2,188 shares — an estimated $234K sold.

Avalon Investment & Advisory first reported a position in DXCM in Q1 2020 and held it in 6 quarters. The position peaked at $14.2M in Q2 2020. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2021.

  • Avalon Investment & Advisory reported no remaining DexCom position as of Q3 2021 after selling out during the quarter.
  • Avalon Investment & Advisory sold 2,188 DexCom shares in Q3 2021, an estimated $234K.
  • Avalon Investment & Advisory first reported a position in DexCom in Q1 2020 and held it in 6 quarters.
  • Avalon Investment & Advisory's DexCom position peaked at $14.2M in Q2 2020.
  • 795 funds tracked by Wall St. Rank held DexCom as of Q3 2021.

Based on Avalon Investment & Advisory's 13F filing for Q3 2021, filed 8 Nov 2021.